SODIUM IODIDE I 123 (sodium iodide i 123) by Integrated Biosciences is clinical pharmacology sodium iodide i 123 is readily absorbed from the upper gastrointestinal tract. First approved in 1982.
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
Sodium Iodide I 123 is a radioactive diagnostic agent administered orally as a capsule for thyroid imaging and functional assessment. It is absorbed from the gastrointestinal tract, concentrated selectively by the thyroid gland, and used to map thyroid anatomy and identify normal versus abnormal functioning tissue. The agent measures thyroid function by quantifying iodide accumulation, with normal subjects accumulating approximately 10-50% of the administered dose.
Product is approaching loss of exclusivity with minimal commercial infrastructure; limited career growth potential in brand-focused roles.
CLINICAL PHARMACOLOGY Sodium Iodide I 123 is readily absorbed from the upper gastrointestinal tract. Following absorption, the iodide is distributed primarily within the extracellular fluid of the body. It is trapped and organically bound by the thyroid and concentrated by the stomach, choroid…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career opportunities on Sodium Iodide I 123 are extremely limited, with only one linked administrative customer service role currently identified. This product represents a maintenance-stage asset with minimal commercial infrastructure, offering little upside for career advancement or skill development in pharmaceutical marketing or medical science.
Worked on SODIUM IODIDE I 123 at Integrated Biosciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
1 open roles linked to this drug
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo